Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
General population screening for type 1 diabetes: Has its time come?
Curr. Opin. Endocrinol. Diabetes Obes. 22, 270-276 (2015)
PURPOSE OF REVIEW: The purpose of this review was to describe the potential for general childhood population-based screening of risk of symptomatic type 1 diabetes (T1D) RECENT FINDINGS: The earliest stages of T1D can be identified and risk and rate of progression to symptomatic disease can be estimated by the presence of multiple islet autoantibodies and glucose intolerance (dysglycemia) in individuals screened for risk. Screening for human leukocyte antigen risk genotypes in neonates with follow-up detection of islet autoantibodies in childhood has been explored. An alternative approach of general childhood population-based detection of autoantibodies at well child visits provides an approach to detect a high proportion of children who will develop T1D. The Fr1da study was launched in Bavaria in 2015 to explore this concept. SUMMARY: General childhood population-based screening for risk of T1D will allow detection of an at-risk population that can participate in natural history studies to better understand disease pathogenesis and intervention trials to prevent symptomatic disease and will provide a framework for public health-based prevention of childhood-onset T1D.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
3.367
1.424
27
34
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Disease Staging ; Prevention ; Risk Screening ; Type 1 Diabetes; Multiple Islet Autoantibodies; Follow-up; Children; Risk; Trends; Schoolchildren; Seroconversion; Ketoacidosis; Progression; Prevalence
Sprache
englisch
Veröffentlichungsjahr
2015
HGF-Berichtsjahr
2015
ISSN (print) / ISBN
1752-296X
e-ISSN
1752-2978
Quellenangaben
Band: 22,
Heft: 4,
Seiten: 270-276
Verlag
Lippincott Williams & Wilkins
Verlagsort
Hagerstown, Md.
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Diabetes Research (IDF)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502100-001
PubMed ID
26087338
WOS ID
WOS:000358166700003
Scopus ID
84937774881
Erfassungsdatum
2015-06-20